Drugs Made In America Acquisition Corp. (DMAA)
NasdaqGM · USD · Financial Services · Shell Companies
$10.88 (+0.05%) as of
Key statistics
- Market cap
- 264.13M
- P/E (TTM)
- 60.44
- EPS (TTM)
- 0.18
- Dividend yield
- 0.00%
- 52-week range
- 10.30 – 10.89
- Profit margin
- 0.00%
- Volume
- 11.45k
About Drugs Made In America Acquisition Corp.
Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combinations with one or more businesses. Drugs Made In America Acquisition Corp. was incorporated in 2024 and is based in New York, New York.
- Sector
- Financial Services
- Industry
- Shell Companies
- Headquarters
- New York, NY, United States
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.